Inhibition of Colony-Stimulating Factor-1 Receptor Enhances the Efficacy of Radiotherapy and Reduces Immune Suppression in Glioblastoma

Aim: To use inhibition of colony-stimulating factor-1 receptor (CSF-1R) to target tumor-associated macrophages (TAMs) and improve the efficacy of radiotherapy in glioblastoma (GBM). Materials and Methods: The CSF-1R inhibitor BLZ-945 was used to examine the impact of CSF-1R inhibition on M2 polarization in vitro. Using an orthotopic, immunocompetent GBM model, mice were treated with vehicle, RT, BLZ-945, or RT plus BLZ-945. Results: BLZ-945 reduced M2 polarization in vitro. BLZ-945 alone did not improve median overall survival (mOS=29 days) compared to control mice (mOS=27 days). RT improved survival (mOS=45 days; p=0.02), while RT plus BLZ-945 led to the longest survival (mOS=not reached; p=0.005). Resected tumors had a relatively large population of M2 TAMs in GBM at baseline, which was increased in response to RT. BLZ-945 reduced RT-induced M2 infiltration. Conclusion: Inhibition of CSF-1R improved response to RT in the treatment of GBM and may represent a promising strategy to improve RT-induced antitumor immune responses.

[1]  A. Baschnagel,et al.  Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation , 2020, Head & neck.

[2]  Christopher M. Jackson,et al.  Mechanisms of immunotherapy resistance: lessons from glioblastoma , 2019, Nature Immunology.

[3]  Shiva Kant,et al.  Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma , 2019, Cancer Immunology, Immunotherapy.

[4]  V. Zagonel,et al.  PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review. , 2019, Critical reviews in oncology/hematology.

[5]  D. Ottaviani,et al.  Harnessing the immune system in glioblastoma , 2018, British Journal of Cancer.

[6]  C. Castañeda,et al.  Distribution of tumor-infiltrating immune cells in glioblastoma , 2018, CNS oncology.

[7]  J. Allison,et al.  Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. , 2018, Cancer discovery.

[8]  C. Miller,et al.  Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma , 2018, Clinical Cancer Research.

[9]  M. Ernst,et al.  Targeting Macrophages in Cancer: From Bench to Bedside , 2018, Front. Oncol..

[10]  C. James,et al.  IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma , 2018, Clinical Cancer Research.

[11]  Y. Delneste,et al.  The roles of CSFs on the functional polarization of tumor‐associated macrophages , 2018, The FEBS journal.

[12]  Steven P. Angus,et al.  Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma , 2017, Neuro-oncology.

[13]  Hanmei Xu,et al.  Tumor-related interleukins: old validated targets for new anti-cancer drug development , 2017, Molecular Cancer.

[14]  S. Lucas,et al.  Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies , 2017, Front. Immunol..

[15]  Edward F. Chang,et al.  Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. , 2017, Cancer cell.

[16]  A. Brandes,et al.  OS10.3 Randomized Phase 3 Study Evaluating the Efficacy and Safety of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: CheckMate 143 , 2017 .

[17]  P. Murray.  Macrophage Polarization. , 2017, Annual review of physiology.

[18]  A. Bergenheim,et al.  Radiotherapy induces an immediate inflammatory reaction in malignant glioma: a clinical microdialysis study , 2016, Journal of Neuro-Oncology.

[19]  C. Miller,et al.  Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide. , 2016, Neuro-oncology.

[20]  Sarah I. Alothman,et al.  Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice. , 2016, Gastroenterology.

[21]  J. Brown,et al.  Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization. , 2016, Neuro-oncology.

[22]  Eric C. Holland,et al.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas , 2016, Science.

[23]  M. Prados,et al.  Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. , 2016, Neuro-oncology.

[24]  Xinchen Sun,et al.  Effects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implications. , 2015, American journal of cancer research.

[25]  T. Rőszer,et al.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms , 2015, Mediators of inflammation.

[26]  F. Paris,et al.  Radiation-induced PGE2 sustains human glioma cell growth and survival through EGF signaling , 2015, Oncotarget.

[27]  T. van Dyke,et al.  A preclinical orthotopic model for glioblastoma recapitulates key features of human tumors and demonstrates sensitivity to a combination of MEK and PI3K pathway inhibitors , 2014, Disease Models & Mechanisms.

[28]  Jill S. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 , 2015, Neuro-oncology.

[29]  S. Formenti,et al.  Myeloid-derived cells in tumors: effects of radiation. , 2015, Seminars in radiation oncology.

[30]  C. Miller,et al.  Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis. , 2013, Neuro-oncology.

[31]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[32]  A. Sica,et al.  Macrophage plasticity and polarization in tissue repair and remodelling , 2013, The Journal of pathology.

[33]  J. DeMarco,et al.  Radiation enhances regulatory T cell representation. , 2011, International journal of radiation oncology, biology, physics.

[34]  A. Unterberg,et al.  Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β , 2011, Clinical Cancer Research.

[35]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[36]  David J. Yang,et al.  The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. , 2006, Neuro-oncology.